Two members of Congress launched an investigation into FDA Commissioner Marty Makary, MD, MPH, and his use of "priority vouchers" for expedited drug approvals, suggesting that the voucher program ...
The listening session, held on the FDA’s White Oak Campus, featured 17 speakers representing patient groups, drug companies, ...
Expedited development and review programs established by the US Food and Drug Administration (FDA) have a growing role in bringing drugs and biologics to market, with novel orphan and nonorphan ...
Dr. Marty Makary, commissioner of the Food and Drug Administration, speaks in the Oval Office of the White House during an event with President Donald Trump, Thursday ...
WASHINGTON — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Trump’s administration is causing alarm across the agency, stoking ...
But from the get-go, the program has been plagued by confusion. Critics say the listed priorities are overly vague, the ...
WASHINGTON (AP) — The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically expedited reviews at the agency, part of an effort to ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (AP) — The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results